News and Updates
Emerald Cloud Lab (ECL) is pausing experimentation for the summer as they move into their new and improved facility. The new site boasts a 700% increase in size along with a larger array of equipment -over 230 unique types- enabling new methods of experimentation as well as higher throughput. The new site is set to open in July 2023, and Align to Innovate is wasting no time in continuing our Challenge and Partner programs during the shutdown. ECL’s Command Center® is still up and running for code development throughout their move, ensuring that new code packages and experimentation pipelines can be implemented on day 1 in their new location.
We are pleased to introduce our first three Bioautomation Partners! They will join us to help build the community of open cloud science researchers, develop open source software for experimental biology, and implement new program concepts.
We are opening a search for a full-time program director who will launch a new program focused on collecting large datasets and making automation broadly accessible to the scientific community.
July 15 - We have opened a call for applicants to the Partner Program, an opportunity for individuals to get involved with programmable experiments. Partners will work toward building open-source libraries of cloud lab code, conducting research, building the community, and launching new programs.
May 11—We are pleased to announce the 2022 Bioautomation Challenge Cohort. Nine groups have been selected, including groups spanning seven universities and three continents. This first cohort of awardees will pioneer research science in the cloud by identifying the best use cases of cloud labs in research, writing foundational open-source methods, and gathering the first cloud datasets.
Successfully incorporating automation into life science requires that we acknowledge the importance of the hybrid approach: some workflows are done in-person, other workflows are remotely automated.
Thomas Kalil, Chief Innovation Officer of Schmidt Futures, interviews biomedical engineer Erika DeBenedictis.